Previous Close | 1.0000 |
Open | 0.9000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 10.00 |
Expire Date | 2024-09-20 |
Day's Range | 0.9000 - 1.0000 |
Contract Range | N/A |
Volume | |
Open Interest | 455 |
Key Insights Significant control over Mind Medicine (MindMed) by retail investors implies that the general public has...
NEW YORK, May 28, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following conferences:
NEW YORK, May 09, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences: